Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024

ARAY 10.23.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-06
Name of Upcoming Event:Accuray Conference Call
Full Press ReleaseSEC FilingsOur ARAY Tweets

About Gravity Analytica

Recent News

  • 02.05.2025 - Q2 2025 Accuray Incorporated Earnings Conference Call
  • 01.22.2025 - Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
  • 01.21.2025 - Leonel Peralta to Join Accuray as Chief Operations Officer

Recent Filings

  • 01.21.2025 - 8-K Current report
  • 01.21.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 01.21.2025 - EX-99.1 EX-99.1

MADISON, Wis.,Oct. 23, 2024/PRNewswire/ --Accuray Incorporated(NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, endedSeptember 30, 2024, during a conference call hosted by company management at1:30 p.m. PT/4:30 p.m. ETonNovember 6, 2024.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is 1-877-344-7529 (USA) or 1-412-317-0088 (international), conference ID: 2342044.

A live webcast of the call will also be available from the Investor Relations section of the company's website atinvestors.accuray.com. A webcast replay can be accessed on the website and will remain available untilAccurayannounces its results for the second quarter of fiscal 2025.

AboutAccurayAccurayIncorporated (Nasdaq:ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology,neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster.Accurayis headquartered inMadison, Wisconsin, with facilities worldwide. To learn more, visitwww.accuray.comor follow us onFacebook,LinkedIn,X, andYouTube.

Investor ContactAmanPatel,CFAInvestor Relations,ICR-Westwicke+1 (443) 450-4191aman.patel@westwicke.com

Media ContactBeth KaplanPublic Relations Director,Accuray+1 (408) 789-4426bkaplan@accuray.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-first-quarter-fiscal-2025-financial-results-on-november-6-2024-302284205.html

SOURCEAccuray Incorporated

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com